Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2011 (2011), Article ID 354760, 8 pages
http://dx.doi.org/10.4061/2011/354760
Clinical Study

Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release

1Department of Neurology, University of Technology Dresden, Fetscherstraße 74, 01307 Dresden, Germany
2Neurosciences Center of Excellence, GlaxoSmithKline, Brentford, London TW8 9GS, UK
3Neurosciences Medicines Development Center, GlaxoSmithKline, Uxbridge, London UB11 1BT, UK
4Area of Applied Epidemiology, National Centre for Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid 28029, Spain

Received 6 December 2010; Revised 28 February 2011; Accepted 6 March 2011

Academic Editor: Peter Hagell

Copyright © 2011 Heinz Reichmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Tandberg, J. P. Larsen, and K. Karlsen, “Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study,” Movement Disorders, vol. 14, no. 6, pp. 922–927, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Karlsen, J. P. Larsen, E. Tandberg, and K. Jørgensen, “Fatigue in patients with Parkinson's disease,” Movement Disorders, vol. 14, no. 2, pp. 237–241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. K. R. Chaudhuri, “The basis for day and night-time control of symptoms of Parkinson's disease,” European Journal of Neurology, vol. 9, supplement 3, pp. 40–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Martinez-Martin, A. H. V. Schapira, F. Stocchi et al., “Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients,” Movement Disorders, vol. 22, no. 11, pp. 1623–1629, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. M. Damiano, C. Snyder, B. Strausser, and M. K. Willian, “A review of health-related quality-of-life concepts and measures for Parkinson's disease,” Quality of Life Research, vol. 8, no. 3, pp. 235–243, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. H. Karlsen, E. Tandberg, D. Arsland, and J. P. Larsen, “Health related quality of life in Parkinson's disease: a prospective longitudinal study,” Journal of Neurology Neurosurgery and Psychiatry, vol. 69, no. 5, pp. 584–589, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Shulman, R. L. Taback, A. A. Rabinstein, and W. J. Weiner, “Non-recognition of depression and other non-motor symptoms in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 8, no. 3, pp. 193–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. R. Chaudhuri, L. Yates, and P. Martinez-Martin, “The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential,” Current Neurology and Neuroscience Reports, vol. 5, no. 4, pp. 275–283, 2005. View at Google Scholar · View at Scopus
  9. K. R. Chaudhuri and K. Logishetty, “Dopamine receptor agonists and sleep disturbances in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 15, supplement 4, pp. S101–S104, 2009. View at Publisher · View at Google Scholar
  10. S. Frucht, J. D. Rogers, P. E. Greene, M. F. Gordon, and S. Fahn, “Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole,” Neurology, vol. 52, no. 9, pp. 1908–1910, 1999. View at Google Scholar · View at Scopus
  11. V. Dhawan, D. G. Healy, S. Pal, and K. R. Chaudhuri, “Sleep-related problems of Parkinson's disease,” Age and Ageing, vol. 35, no. 3, pp. 220–228, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. D. Gjerstad, G. Alves, T. Wentzel-Larsen, D. Aarsland, and J. P. Larsen, “Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?” Neurology, vol. 67, no. 5, pp. 853–858, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. C. L. Comella, M. Morrissey, and K. Janko, “Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy,” Neurology, vol. 64, no. 8, pp. 1450–1451, 2005. View at Google Scholar · View at Scopus
  14. B. Högl, A. Rothdach, T. C. Wetter, and C. Trenkwalder, “The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease,” Neuropsychopharmacology, vol. 28, no. 10, pp. 1866–1870, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. D. J. Tompson and D. Vearer, “Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease,” Clinical Therapeutics, vol. 29, no. 12, pp. 2654–2666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. Pahwa, M. A. Stacy, S. A. Factor et al., “Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease,” Neurology, vol. 68, no. 14, pp. 1108–1115, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. F. Stocchi, B. P. Hersh, B. L. Scott et al., “Ropinirole 24-hour prolonged release and ropinirole immediate release in early Parkinson's disease: a randomized, double-blind, non-inferiority crossover study,” Current Medical Research and Opinion, vol. 24, no. 10, pp. 2883–2895, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. B. P. Hersh, N. L. Earl, R. A. Hauser, and M. Stacy, “Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations,” Movement Disorders, vol. 25, no. 7, pp. 927–931, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. GlaxoSmithKline, “Ropinirole XL prolonged-release tablets summary of product characteristics,” February 2011, http://www.medicines.org.uk/emc/medicine/20813/SPC/Requip+XL+prolonged-release+tablets/.
  20. J. Reimer, M. Grabowski, O. Lindvall, and P. Hagell, “Use and interpretation of on/off diaries in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 75, no. 3, pp. 396–400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Dušek, J. Bušková, E. Růžička et al., “Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease,” Clinical Neuropharmacology, vol. 33, no. 4, pp. 186–190, 2010. View at Publisher · View at Google Scholar · View at PubMed